Answers are grounded in this paper and cite their sources.
The clinical manifestations of iris lymphoma are nonspecific and can easily be confused with other ophthalmic diseases, leading to misdiagnosis. This study reports a case of primary testicular diffuse large B-cell lymphoma in a patient who developed isolated iris recurrence after achieving complete remission. Following treatment with a targeted combination regimen consisting of Zanubrutinib, Obinutuzumab, and Polatuzumab vedotin, the patient's disease remained stable, with a follow-up duration of 22 months from treatment initiation to the last follow-up. Relevant literature is reviewed to summarize the clinical characteristics and treatment strategies for iris lymphoma, aiming to enhance clinicians' awareness of this rare pattern of ocular recurrence and provide insights for its management.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: